Swiss Supreme Court Freezes Doctor Over Assisted Suicide Conviction
In a dramatic twist, the Federal Court in Switzerland has reversed a conviction that had felled a Geneva physician. It will now decide whether he should face charges under a different law – the Narcotics Act – rather than the Therapeutic Products Act (TPA) that originally sparked the case.
What Went Down?
- The doctor, whose name remains confidential, prescribed sodium pentobarbital to an 86‑year‑old woman in 2017.
- She took the drug to end her life, hoping she wouldn’t have to outlive her husband, who was terminally ill.
- The court found that the drug was used for “suicide by a healthy person,” a scenario in which no medical indication justifies prescription.
- Because pentobarbital is not a therapeutic agent in the broad sense, the conviction under the TPA was ruled invalid.
Why the Law Matters
Assisted suicide isn’t a stranger in Switzerland – it’s legal since the 1940s, which has earned the country the nickname “death tourism” magnet. But statutes like the TPA and the Narcotics Act are designed for different contexts.
Next Steps
The Federal Court has sent the case back to the lower court to determine whether the doctor should face charges under the Narcotics Act instead. This means the doctor’s legal fate is still hanging in the balance.
A Quick Take
- Doctor gets a clean bill of health under the TPA?
- New questions raised under the Narcotics Act?
- Swiss legal system keeps evolving when it comes to assisted death.
Bottom line: Who knew a legal battle over a prescription could make headline news? Stay tuned for updates on this evolving saga.
